Sergio Traversa - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Sergio Traversa is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $891K. Historical track record: 4/5 stars across 5 tracked purchases.
Profile
Sergio Traversa serves as Chief Executive Officer of RELMADA THERAPEUTICS, INC. (RLMD). Traversa has reported 5 insider filings with the SEC since 2025. The most recent filing was in December 2025.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 40/100 |
Board memberships
- RELMADA THERAPEUTICS, INC.
Reported roles
- Chief Executive Officer
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★☆ (4/5) |
|---|---|
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 80% |
| 90-day win rate | 100% |
| Avg 5-day return | +66.58% |
| Avg 30-day return | +104.18% |
| Avg 90-day return | +324.04% |
| Best 30-day return | +170.35% |
Trading Pattern
InsiderAlpha's records for Sergio Traversa go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. The typical open-market purchase is $178K (5 buys totaling $891K). The largest single buy on record is $600K of RLMD in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Sergio Traversa has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Executive Officer, Director at RELMADA THERAPEUTICS, INC. (RLMD) - 3 filings, 2025
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-16 | RLMD | RELMADA THERAPEUTICS, INC. | P - Open-market purchase | 27.5K | $4.12 | $113K |
| 2025-11-06 | RLMD | RELMADA THERAPEUTICS, INC. | P - Open-market purchase | 272.5K | $2.20 | $600K |
| 2025-08-28 | RLMD | RELMADA THERAPEUTICS, INC. | P - Open-market purchase | 56.0K | $0.74 | $41K |
| 2025-08-28 | RLMD | RELMADA THERAPEUTICS, INC. | P - Open-market purchase | 129.5K | $0.67 | $87K |
| 2025-08-28 | RLMD | RELMADA THERAPEUTICS, INC. | P - Open-market purchase | 80.5K | $0.62 | $50K |
Most Active Insiders Right Now
Sergio Traversa has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Thomas J. Shaw
- Silver Point Capital L.P.
- SilverBay Capital Management LLC
- Michael Simanovsky
- Bob R. Simpson
- Ranbir Singh
- Ross Jeffery Sklar
- Barry Sloane
Frequently Asked Questions
Who is Sergio Traversa?
Sergio Traversa serves as Chief Executive Officer of RELMADA THERAPEUTICS, INC. (RLMD). Traversa has reported 5 insider filings with the SEC since 2025. The most recent filing was in December 2025.…
Has Sergio Traversa been buying or selling stock?
Recorded transactions: 5 open-market purchases ($891K) and 0 open-market sales across all tracked filings.
How accurate is Sergio Traversa's historical track record?
Across 5 tracked purchases, Sergio Traversa averaged +104.2% avg 30-day return with a 80% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
Where can I see all of Sergio Traversa's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Sergio Traversa profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.